Clinical Trials Browser

Phase 1 × Glioblastoma × Tetanus Toxoid × Clear all

NCT00639639 2023-03-13

ATTAC

Phase 1 Completed

Glioblastoma, Gliosarcoma

NCT02864368 2022-06-09

PERFORMANCE

Phase 1 Terminated

27 enrolled 13 charts

Glioblastoma